The global prevalence of colon cancer points to effective treatment strategies for the prevention and treatment of colon cancers.
The large Adjuvant Colon Cancer End points (ACCENT) database with individual patient data for 20 898 patients enroled on 18 colon cancer clinical trials pre-dated the biologically targeted therapeutic approaches described above (Sargent et al, 2005, 2007).
Here, we report on the association between these end points by race, sex, cancer site (colon vs rectum and left colon vs right colon), stage (localised vs regional/distant) and in strata of established risk factors for colorectal cancer.
Endoscopic scoring was performed as previously described: assessment of colon thickening (0 3 points), fibrinization (0 3 points), granularity (0 3 points), morphology of the vascular pattern (0 3 points), and stool consistency (normal to unshaped; 0 3 points) (Becker et al., 2006).
How does Ms. Truss describe the exclamation point, colons, and the "power of the semi-colon," as quoted in the article?
Interestingly, a large percentage of the plant phytochemicals shows a high degree of chemical similarity with metabolites of the human colon metabolic network pointing out that the therapeutic effect of these plants could be mediated at a metabolic level; however, we should not overlook the high similarity between FDA drugs and plant phytochemicals and especially anticancer drugs.
Less forgivable is her habit of trying to pump up the text with colons and exclamation points: Like this!
The chronic laxative abuser risks damaging the natural cycle of their colon to the point where they cannot defecate without a large dosage of laxatives.
The CuRosebudppeal oneCrunch.
Numerous independent studies have reported the specific overrepresentation of AIEC species in biopsies from patients with CD, ulcerative colitis and colon cancer, thus pointing to this pathotype as an important culprit in determining the onset and perpetuation of inflammatory bowel diseases [5] [13].
We included only case control or cohort studies with a colon cancer end point.
